BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spencer AU, Yang H, Haxhija EQ, Wildhaber BE, Greenson JK, Teitelbaum DH. Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Dig Dis Sci 2007;52:1060-70. [PMID: 17342403 DOI: 10.1007/s10620-006-9124-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Guimarães VHD, Marinho BM, Motta-Santos D, Mendes GDRL, Santos SHS. Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome. J Nutr Biochem 2022;113:109252. [PMID: 36509338 DOI: 10.1016/j.jnutbio.2022.109252] [Reference Citation Analysis]
2 Lo SW, Segal JP, Lubel JS, Garg M. What do we know about the renin angiotensin system and inflammatory bowel disease? Expert Opin Ther Targets 2022;26:897-909. [PMID: 36484415 DOI: 10.1080/14728222.2022.2157261] [Reference Citation Analysis]
3 Jaworska K, Kopacz W, Koper M, Szudzik M, Gawryś-kopczyńska M, Konop M, Hutsch T, Chabowski D, Ufnal M. Enalapril Diminishes the Diabetes-Induced Changes in Intestinal Morphology, Intestinal RAS and Blood SCFA Concentration in Rats. IJMS 2022;23:6060. [DOI: 10.3390/ijms23116060] [Reference Citation Analysis]
4 Wei X, Li X, Du J, Ge X, Sun Y, Li X, Xun Z, Liu W, Wang ZY, Li YC. Vitamin D Deficiency Exacerbates Colonic Inflammation Due to Activation of the Local Renin-Angiotensin System in the Colon. Dig Dis Sci 2021;66:3813-21. [PMID: 33433800 DOI: 10.1007/s10620-020-06713-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Hachiya K, Masuya M, Kuroda N, Yoneda M, Tsuboi J, Nagaharu K, Nishimura K, Shiotani T, Ohishi K, Tawara I, Katayama N. Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway. Sci Rep 2021;11:19943. [PMID: 34620946 DOI: 10.1038/s41598-021-99412-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Jaworska K, Koper M, Ufnal M. Gut microbiota and renin-angiotensin system: a complex interplay at local and systemic levels. Am J Physiol Gastrointest Liver Physiol 2021;321:G355-66. [PMID: 34405730 DOI: 10.1152/ajpgi.00099.2021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
7 Salmenkari H, Korpela R, Vapaatalo H. Renin-angiotensin system in intestinal inflammation-Angiotensin inhibitors to treat inflammatory bowel diseases? Basic Clin Pharmacol Toxicol 2021;129:161-72. [PMID: 34128327 DOI: 10.1111/bcpt.13624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mantaka A, Tsoukali E, Fragkaki M, Karmiris K, Viazis N, Mantzaris GJ, Koutroubakis IE. Is there any role of renin-angiotensin system inhibitors in modulating inflammatory bowel disease outcome? Eur J Gastroenterol Hepatol 2021;33:364-71. [PMID: 32925506 DOI: 10.1097/MEG.0000000000001912] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
9 Barbalho SM, Matias JN, Flato UAP, Pilon JPG, Bitelli P, Pagani Junior MA, de Carvalho ACA, Haber JFDS, Reis CHB, Goulart RA. What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease? Gastroenterology Res 2021;14:1-12. [PMID: 33737994 DOI: 10.14740/gr1358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Garg M, Royce SG, Tikellis C, Shallue C, Batu D, Velkoska E, Burrell LM, Patel SK, Beswick L, Jackson A, Britto K, Lukies M, Sluka P, Wardan H, Hirokawa Y, Tan CW, Faux M, Burgess AW, Hosking P, Monagle S, Thomas M, Gibson PR, Lubel J. Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? Gut 2020;69:841-51. [PMID: 31409604 DOI: 10.1136/gutjnl-2019-318512] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 38.0] [Reference Citation Analysis]
11 Sueyoshi R, Miyahara K, Nakazawa-Tanaka N, Fujiwara N, Ochi T, Yamataka A. DPP4 inhibitor reinforces cell junction proteins in mouse model of short bowel syndrome. Pediatr Surg Int 2020;36:49-55. [PMID: 31576468 DOI: 10.1007/s00383-019-04571-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 He L, Du J, Chen Y, Liu C, Zhou M, Adhikari S, Rubin DT, Pekow J, Li YC. Renin-angiotensin system promotes colonic inflammation by inducing T(H)17 activation via JAK2/STAT pathway. Am J Physiol Gastrointest Liver Physiol 2019;316:G774-84. [PMID: 30995068 DOI: 10.1152/ajpgi.00053.2019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
13 Salmenkari H, Laitinen A, Forsgård RA, Holappa M, Lindén J, Pasanen L, Korhonen M, Korpela R, Nystedt J. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study. Cytotherapy 2019;21:175-88. [PMID: 30611671 DOI: 10.1016/j.jcyt.2018.11.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
14 Ranjbar R, Shafiee M, Hesari A, Ferns GA, Ghasemi F, Avan A. The potential therapeutic use of renin-angiotensin system inhibitors in the treatment of inflammatory diseases. J Cell Physiol 2019;234:2277-95. [PMID: 30191985 DOI: 10.1002/jcp.27205] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
15 Salmenkari H, Holappa M, Siltari A, Korpela R, Vapaatalo H. Local Intestinal ACE-Like Activity and Corticosterone Production in Hypertensive and Aging Rats. PP 2018;09:27-37. [DOI: 10.4236/pp.2018.91003] [Reference Citation Analysis]
16 Salmenkari H, Holappa M, Siltari A, Korpela R, Vapaatalo H. Local Intestinal ACE-Like Activity and Corticosterone Production in Hypertensive and Aging Rats. PP 2018;09:27-37. [DOI: 10.4236/pp.2018.91008] [Reference Citation Analysis]
17 Zizzo MG, Auteri M, Amato A, Caldara G, Nuzzo D, Di Carlo M, Serio R. Angiotensin II type II receptors and colonic dysmotility in 2,4-dinitrofluorobenzenesulfonic acid-induced colitis in rats. Neurogastroenterol Motil 2017;29. [PMID: 28160390 DOI: 10.1111/nmo.13019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
18 Patten GS, Abeywardena MY. Effects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by Losartan. J Pharmacol Exp Ther 2017;360:260-6. [PMID: 27903643 DOI: 10.1124/jpet.116.237586] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
19 Okawada M, Wilson MW, Larsen SD, Lipka E, Hillfinger J, Teitelbaum DH. Blockade of the renin-angiotensin system prevents acute and immunologically relevant colitis in murine models. Pediatr Surg Int 2016;32:1103-14. [PMID: 27670279 DOI: 10.1007/s00383-016-3965-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Shi Y, Liu T, He L, Dougherty U, Chen L, Adhikari S, Alpert L, Zhou G, Liu W, Wang J, Deb DK, Hart J, Liu SQ, Kwon J, Pekow J, Rubin DT, Zhao Q, Bissonnette M, Li YC. Activation of the Renin-Angiotensin System Promotes Colitis Development. Sci Rep 2016;6:27552. [PMID: 27271344 DOI: 10.1038/srep27552] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
21 Khajah MA, Fateel MM, Ananthalakshmi KV, Luqmani YA. Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis. PLoS One 2016;11:e0150861. [PMID: 26963721 DOI: 10.1371/journal.pone.0150861] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 8.6] [Reference Citation Analysis]
22 Leonel AJ, Silva EL, Aguilar EC, Teixeira LG, Oliveira RP, Faria AMC, Cara DC, Ferreira LAM, Alvarez‐leite JI. Systemic administration of a nanoemulsion with tributyrin reduces inflammation in experimental colitis. Eur J Lipid Sci Technol 2016;118:157-164. [DOI: 10.1002/ejlt.201400359] [Reference Citation Analysis]
23 Zorzi F, Calabrese E, Monteleone G. Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease. Clin Sci (Lond) 2015;129:1107-13. [PMID: 26494636 DOI: 10.1042/CS20150472] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
24 Liu TJ, Shi YY, Wang EB, Zhu T, Zhao Q. AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease. Mol Med Rep 2016;13:1156-62. [PMID: 26676112 DOI: 10.3892/mmr.2015.4686] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
25 Mastropaolo M, Zizzo MG, Auteri M, Caldara G, Liotta R, Mulè F, Serio R. Activation of angiotensin II type 1 receptors and contractile activity in human sigmoid colon in vitro. Acta Physiol (Oxf) 2015;215:37-45. [PMID: 26052867 DOI: 10.1111/apha.12538] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
26 Sueyoshi R, Woods Ignatoski KM, Okawada M, Hartmann B, Holst J, Teitelbaum DH. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model. Am J Physiol Gastrointest Liver Physiol 2014;307:G410-9. [PMID: 24970775 DOI: 10.1152/ajpgi.00363.2013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
27 Bettenworth D, Rieder F. Medical therapy of stricturing Crohn’s disease: what the gut can learn from other organs - a systematic review. Fibrogenesis Tissue Repair. 2014;7:5. [PMID: 24678903 DOI: 10.1186/1755-1536-7-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
28 Garg M, Burrell LM, Velkoska E, Griggs K, Angus PW, Gibson PR, Lubel JS. Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study. J Renin Angiotensin Aldosterone Syst 2015;16:559-69. [PMID: 24505094 DOI: 10.1177/1470320314521086] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 5.8] [Reference Citation Analysis]
29 Hume GE, Radford-smith GL. ACE inhibitors and angiotensin II receptor antagonists in Crohn’s disease management. Expert Review of Gastroenterology & Hepatology 2014;2:645-51. [DOI: 10.1586/17474124.2.5.645] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
30 Lee C, Chun J, Hwang SW, Kang SJ, Im JP, Kim JS. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice. Life Sci 2014;95:29-39. [PMID: 24239644 DOI: 10.1016/j.lfs.2013.11.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
31 Sueyoshi R, Woods Ignatoski KM, Okawada M, Teitelbaum DH. Distraction-induced intestinal growth: the role of mechanotransduction mechanisms in a mouse model of short bowel syndrome. Tissue Eng Part A. 2014;20:830-841. [PMID: 24070252 DOI: 10.1089/ten.tea.2013.0383] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
32 Sueyoshi R, Ignatoski KM, Daignault S, Okawada M, Teitelbaum DH. Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model. Dig Dis Sci 2013;58:3165-77. [PMID: 23949641 DOI: 10.1007/s10620-013-2825-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
33 Sueyoshi R, Ralls MW, Teitelbaum DH. Glucagon-like peptide 2 increases efficacy of distraction enterogenesis. J Surg Res 2013;184:365-73. [PMID: 23639355 DOI: 10.1016/j.jss.2013.03.089] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
34 Leonel AJ, Teixeira LG, Oliveira RP, Santiago AF, Batista NV, Ferreira TR, Santos RC, Cardoso VN, Cara DC, Faria AM, Alvarez-Leite J. Antioxidative and immunomodulatory effects of tributyrin supplementation on experimental colitis. Br J Nutr 2013;109:1396-407. [PMID: 22906779 DOI: 10.1017/S000711451200342X] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
35 Garg M, Angus PW, Burrell LM, Herath C, Gibson PR, Lubel JS. Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract. Aliment Pharmacol Ther 2012;35:414-28. [PMID: 22221317 DOI: 10.1111/j.1365-2036.2011.04971.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 92] [Article Influence: 8.5] [Reference Citation Analysis]
36 Okawada M, Koga H, Larsen SD, Showalter HD, Turbiak AJ, Jin X, Lucas PC, Lipka E, Hillfinger J, Kim JS, Teitelbaum DH. Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitis. Dig Dis Sci 2011;56:2553-65. [PMID: 21399927 DOI: 10.1007/s10620-011-1651-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
37 Okawada M, Holst JJ, Teitelbaum DH. Administration of a dipeptidyl peptidase IV inhibitor enhances the intestinal adaptation in a mouse model of short bowel syndrome. Surgery. 2011;150:217-223. [PMID: 21719060 DOI: 10.1016/j.surg.2011.05.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
38 Okawada M, Maria HM, Teitelbaum DH. Distraction induced enterogenesis: a unique mouse model using polyethylene glycol. J Surg Res 2011;170:41-7. [PMID: 21605872 DOI: 10.1016/j.jss.2011.03.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
39 Fändriks L. The renin-angiotensin system and the gastrointestinal mucosa. Acta Physiol (Oxf) 2011;201:157-67. [PMID: 20626369 DOI: 10.1111/j.1748-1716.2010.02165.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
40 Motta J, Martin L, Vergnolle N. Proteases/Antiproteases in Inflammatory Bowel Diseases. Proteases and Their Receptors in Inflammation 2011. [DOI: 10.1007/978-3-0348-0157-7_8] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Sansom SE, Nuovo GJ, Martin MM, Kotha SR, Parinandi NL, Elton TS. miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells. Am J Physiol Gastrointest Liver Physiol 2010;299:G632-42. [PMID: 20558762 DOI: 10.1152/ajpgi.00120.2010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
42 Miyasaka EA, Okawada M, Utter B, Mustafa-Maria H, Luntz J, Brei D, Teitelbaum DH. Application of distractive forces to the small intestine: defining safe limits. J Surg Res 2010;163:169-75. [PMID: 20605600 DOI: 10.1016/j.jss.2010.03.060] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
43 Hindryckx P, Waeytens A, Laukens D, Peeters H, Van Huysse J, Ferdinande L, Carmeliet P, De Vos M. Absence of placental growth factor blocks dextran sodium sulfate-induced colonic mucosal angiogenesis, increases mucosal hypoxia and aggravates acute colonic injury. Lab Invest. 2010;90:566-576. [PMID: 20142801 DOI: 10.1038/labinvest.2010.37] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
44 Mizushima T, Sasaki M, Ando T, Wada T, Tanaka M, Okamoto Y, Ebi M, Hirata Y, Murakami K, Mizoshita T, Shimura T, Kubota E, Ogasawara N, Tanida S, Kataoka H, Kamiya T, Alexander JS, Joh T. Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis. Am J Physiol Gastrointest Liver Physiol 2010;298:G255-66. [PMID: 19940029 DOI: 10.1152/ajpgi.00264.2009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
45 Byrnes JJ, Gross S, Ellard C, Connolly K, Donahue S, Picarella D. Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice. Inflamm Res 2009;58:819-27. [DOI: 10.1007/s00011-009-0053-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
46 Koga H, Yang H, Haxhija EQ, Teitelbaum DH. The role of angiotensin II type 1a receptor on intestinal epithelial cells following small bowel resection in a mouse model. Pediatr Surg Int 2008;24:1279-86. [PMID: 18989682 DOI: 10.1007/s00383-008-2277-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
47 Koga H, Yang H, Adler J, Zimmermann EM, Teitelbaum DH. Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment. Surgery 2008;144:259-68. [PMID: 18656634 DOI: 10.1016/j.surg.2008.03.043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
48 Haxhija EQ, Yang H, Spencer AU, Koga H, Sun X, Teitelbaum DH. Modulation of mouse intestinal epithelial cell turnover in the absence of angiotensin converting enzyme. Am J Physiol Gastrointest Liver Physiol 2008;295:G88-98. [PMID: 18483182 DOI: 10.1152/ajpgi.00589.2007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]